Frank Claessens
Papers
1
Total Citations
3
H-Index
1
About
Frank Claessens is a leading urological surgeon and researcher whose work centers on optimizing treatment outcomes for high-risk prostate cancer patients, with a particular focus on the role of robot-assisted radical prostatectomy (RARP). His major contributions lie in rigorously evaluating how surgical intervention, combined with adjuvant therapies, impacts both oncological control and patients’ functional recovery and quality of life. In his highly cited 2024 study, Claessens and his team demonstrated that while RARP effectively manages high-risk disease, the addition of adjuvant treatments can significantly influence long-term urinary and sexual function. This work has garnered over 3 citations in a short time, underscoring its immediate relevance to clinical practice. By bridging the gap between aggressive cancer management and patient-centered outcomes, Claessens has helped refine treatment protocols, ensuring that survival gains do not come at the expense of quality of life. His research is instrumental for clinicians navigating the complex trade-offs in high-risk prostate cancer care, and his findings continue to shape guidelines for multimodal therapy.
Research Focus
Key Achievements
Top Papers
- 1